The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry. Partnerships between pharmaceutical companies and academic institutes and the rising number of drug discovery programs will boost market growth. Increasing expenditure on research and development by pharmaceutical and biotech companies would also contribute to market growth. Bio-Rad Laboratories, General Electric, Bioptix, Attana, Ametek, Inc., Corning, Inc., Pall Corporation, Danaher Corporation, X-body Biosciences and Roche Diagnostics are some players in this market.